Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 26:9:1018.
doi: 10.3389/fphys.2018.01018. eCollection 2018.

Inositol 1,4,5-Trisphosphate Receptors in Hypertension

Affiliations
Review

Inositol 1,4,5-Trisphosphate Receptors in Hypertension

Ali H Eid et al. Front Physiol. .

Abstract

Chronic hypertension remains a major cause of global mortality and morbidity. It is a complex disease that is the clinical manifestation of multiple genetic, environmental, nutritional, hormonal, and aging-related disorders. Evidence supports a role for vascular aging in the development of hypertension involving an impairment in endothelial function together with an alteration in vascular smooth muscle cells (VSMCs) calcium homeostasis leading to increased myogenic tone. Changes in free intracellular calcium levels ([Ca2+] i ) are mediated either by the influx of Ca2+ from the extracellular space or release of Ca2+ from intracellular stores, mainly the sarcoplasmic reticulum (SR). The influx of extracellular Ca2+ occurs primarily through voltage-gated Ca2+ channels (VGCCs), store-operated Ca2+ channels (SOC), and Ca2+ release-activated channels (CRAC), whereas SR-Ca2+ release occurs through inositol trisphosphate receptor (IP3R) and ryanodine receptors (RyRs). IP3R-mediated SR-Ca2+ release, in the form of Ca2+ waves, not only contributes to VSMC contraction and regulates VGCC function but is also intimately involved in structural remodeling of resistance arteries in hypertension. This involves a phenotypic switch of VSMCs as well as an alteration of cytoplasmic Ca2+ signaling machinery, a phenomena tightly related to the aging process. Several lines of evidence implicate changes in expression/function levels of IP3R isoforms in the development of hypertension, VSMC phenotypic switch, and vascular aging. The present review discusses the current knowledge of these mechanisms in an integrative approach and further suggests potential new targets for hypertension management and treatment.

Keywords: Ca2+; IP3R; VSMC; aging; hypertension.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Proposed role of alteration in IP3R expression/function in the development of hypertension. Apart from contribution to vascular tone and VSM contractility via SR-Ca2+ release, calcium wave production, and induction of calcium sensitization, IP3R forms a mechanosensing complex with TRP channels that is proposed to initiate contraction in response to increased intraluminal pressure. Physiological patterns of IP3R-mediated Ca2+ release are affected by the expression of other SR membrane proteins including SERCA. Under circumstances of sustained increased blood pressure, IP3R expression increases together with increased sensitivity to IP3 and increased coupling with the TRP mechanosensing machinery resulting in increased intracellular Ca2+ release and increased VSM contraction. Interplay with NFAT-mediated signaling pathways might contribute pressure-induced changes in VSMC phenotype, vascular inflammation, and VSMC senescence. Increased VSMC proliferation and migration were reported to involve increased IP3R-mediated Ca2+ release with subsequent intracellular store depletion and increased store-operated Ca2+ entry. IP3R-mediated Ca2+ release can potentially relay apoptotic signaling to the mitochondria contributing to vascular aging.

References

    1. Abd El-Rahman R. R., Harraz O. F., Brett S. E., Anfinogenova Y., Mufti R. E., Goldman D., et al. (2013). Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone development. Am. J. Physiol. Heart Circ. Physiol. 304 H58–H71. 10.1152/ajpheart.00476.2012 - DOI - PMC - PubMed
    1. Abou-Saleh H., Pathan A. R., Daalis A., Hubrack S., Abou-Jassoum H., Al-Naeimi H., et al. (2013). Inositol 1,4,5-trisphosphate (IP3) receptor up-regulation in hypertension is associated with sensitization of Ca2+ release and vascular smooth muscle contractility. J. Biol. Chem. 288 32941–32951. 10.1074/jbc.M113.496802 - DOI - PMC - PubMed
    1. Adebiyi A., Thomas-Gatewood C. M., Leo M. D., Kidd M. W., Neeb Z. P., Jaggar J. H. (2012). An elevation in physical coupling of type 1 inositol 1,4,5-trisphosphate (IP3) receptors to transient receptor potential 3 (TRPC3) channels constricts mesenteric arteries in genetic hypertension. Hypertension 60 1213–1219. 10.1161/hypertensionaha.112.198820 - DOI - PMC - PubMed
    1. Adebiyi A., Zhao G., Narayanan D., Thomas-Gatewood C. M., Bannister J. P., Jaggar J. H. (2010). Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility. Circ. Res. 106 1603–1612. 10.1161/CIRCRESAHA.110.216804 - DOI - PMC - PubMed
    1. Afroze T., Sadi A. M., Momen M. A., Gu S., Heximer S., Husain M. (2007). c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27 1305–1311. 10.1161/ATVBAHA.107.142059 - DOI - PubMed